JULIA ST CLAIR: Open Payments
NPI 1427480466 · ANDERSON, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,915 in 101 payments from 16 companies in 2025. Trend: 2023 $1,039 · 2024 $1,999 · 2025 $1,915
Food & beverage: $1,915
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $416 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $223 |
| Ardelyx, Inc. | 8 | $219 |
| Janssen Biotech, Inc. | 9 | $177 |
| Madrigal Pharmaceuticals | 6 | $147 |
| PFIZER INC. | 6 | $124 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $118 |
| Regeneron Healthcare Solutions, Inc. | 4 | $112 |
| VIVUS LLC | 4 | $83 |
| QOL Medical, LLC | 4 | $78 |
Products named: RINVOQ, IBSRELA, TREMFYA, ENTYVIO, REZDIFFRA, DUPIXENT, LINZESS, VELSIPITY.
Industry payments across IN — which companies pay providers there.
